Afya (NASDAQ:AFYA) Cut to “Underweight” at Morgan Stanley

Morgan Stanley cut shares of Afya (NASDAQ:AFYA) from an equal weight rating to an underweight rating in a research report released on Tuesday, Marketbeat Ratings reports. Morgan Stanley currently has $17.00 price target on the stock, down from their previous price target of $19.00.

A number of other research analysts also recently issued reports on AFYA. JPMorgan Chase & Co. reduced their price target on Afya from $25.00 to $20.50 and set a “neutral” rating on the stock in a report on Friday, January 17th. Citigroup reissued a “sell” rating and issued a $15.00 price target (down from $18.00) on shares of Afya in a research report on Friday, January 31st. Finally, The Goldman Sachs Group started coverage on Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price objective on the stock. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. Based on data from MarketBeat, Afya has a consensus rating of “Reduce” and an average target price of $17.60.

Afya Trading Up 0.4 %

Shares of AFYA stock opened at $16.22 on Tuesday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $16.36 and a two-hundred day moving average price of $16.45. Afya has a 12-month low of $14.52 and a 12-month high of $22.24. The firm has a market cap of $1.52 billion, a P/E ratio of 13.08, a price-to-earnings-growth ratio of 0.29 and a beta of 0.82.

Hedge Funds Weigh In On Afya

A number of large investors have recently made changes to their positions in the business. Public Employees Retirement System of Ohio purchased a new stake in shares of Afya during the third quarter valued at $34,000. Blue Trust Inc. boosted its stake in shares of Afya by 296.9% during the 4th quarter. Blue Trust Inc. now owns 2,072 shares of the company’s stock worth $35,000 after acquiring an additional 1,550 shares in the last quarter. Tower Research Capital LLC TRC raised its position in shares of Afya by 1,099.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company’s stock worth $64,000 after purchasing an additional 3,695 shares during the last quarter. Quarry LP acquired a new position in shares of Afya during the 3rd quarter worth about $75,000. Finally, JPMorgan Chase & Co. raised its holdings in Afya by 2,115.9% in the 4th quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company’s stock valued at $106,000 after acquiring an additional 6,369 shares during the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.